Seraph 100

DEVICE2 trials

Sponsors

Hannover Medical School, ExThera Medical Corporation

Conditions

COVID-19

Unknown Phase

Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter

Hannover Medical SchoolCOVID-19

Start: 2020-04-15End: 2021-10-01Target: 100Updated: 2020-04-24

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19

Active, not recruitingNCT04547257

ExThera Medical CorporationCOVID-19

Start: 2021-05-04End: 2027-06-30Target: 42Updated: 2026-04-20

Related Papers

#2880 Results of the COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter (COSA) registry

Nephrology Dialysis Transplantation2025-10-01

MO669FIRST RESULTS OF THE COVID-19 PATIENTS TREATED WITH THE SERAPH® 100 MICROBIND® AFFINITY FILTER (COSA) REGISTRY

Nephrology Dialysis Transplantation2021-05-013 citations